アフターアワーズ： 25.27

Xoma Corporation (XOMAO)

Xoma Corporation (XOMAO) 最新ニュース

Xoma Corporation (XOMAO)

Xoma Corporation (XOMAO) 最新ニュース

How To Trade (XOMA) - Stock Traders Daily

XOMA (NASDAQ:XOMA) Shares Pass Above Two Hundred Day Moving Average of $22.95 - Defense World

XOMA (NASDAQ:XOMA) Shares Pass Above 200 Day Moving Average of $22.95 - MarketBeat

Xoma (XOMA) Soars 15.6%: Is Further Upside Left in the Stock? - Yahoo Finance

XOMA Declares Quarterly Preferred Stock Dividends | XOMAO Stock News - StockTitan

XOMA Declares Quarterly Preferred Stock Dividends - GlobeNewswire

XOMA Declares Quarterly Preferred Stock Dividends - GlobeNewswire

XOMA Declares Quarterly Preferred Stock Dividends - Yahoo Finance

Xoma: 3Q Earnings Snapshot - Yahoo Singapore News

How a well-traveled brain cancer drug turned into an $8 million payday for an East Bay firm - The Business Journals

How a well-traveled brain cancer drug turned into an $8 million payday for an East Bay firm - The Business Journals

Objective long/short (XOMAO) Report - Stock Traders Daily

Opaleye Management Inc. Sells 24500 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World

XOMA Co. (NASDAQ:XOMAO) Sees Large Decrease in Short Interest - Defense World

Institutional investors control 35% of XOMA Corporation (NASDAQ:XOMA) and were rewarded last week after stock increased 11% - Simply Wall St

Xoma receives $8.1M milestone related to Day One's sale of PRV - TipRanks.com - TipRanks

XOMA Co. (NASDAQ:XOMAP) Short Interest Down 33.3% in May - Defense World

XOMA receives $8.1 million from Viracta Therapeutics By Investing.com - Investing.com Australia

XOMA receives $8.1 million from Viracta Therapeutics By Investing.com - Investing.com

Xoma (XOMA) Moves 7.7% Higher: Will This Strength Last? - Yahoo Movies Canada

XOMA receives $8.1 million from Viracta Therapeutics By Investing.com - Investing.com

XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher - ForexTV.com

XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals' Sale of its Priority Review Voucher - GlobeNewswire

XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals' Sale of its Priority Review Voucher - Yahoo Finance

XOMA receives $8.1 million from Viracta Therapeutics By Investing.com - Investing.com

XOMA (NASDAQ:XOMA) Stock Crosses Above 200-Day Moving Average of $22.10 - MarketBeat

XOMA (NASDAQ:XOMA) Stock Crosses Above 200-Day Moving Average of $22.10 - MarketBeat

LadRx, ImmunityBio mutually agree to terminate Aldoxorubicin license - TipRanks.com - TipRanks

XOMA (NASDAQ:XOMAP) Stock Price Down 0.6% - Defense World

How to Take Advantage of moves in (XOMAO) - Stock Traders Daily

Trend Tracker for (XOMA) - Stock Traders Daily

XOMA (NASDAQ:XOMAO) Trading 0.5% Higher - Defense World

LadRx and ImmunityBio Mutually Agree to Terminate Aldoxorubicin License - Business Wire

XOMA's (XOMA) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

XOMA (NASDAQ:XOMA) Rating Reiterated by HC Wainwright - MarketBeat

Xoma (XOMA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo New Zealand News

Peeling Back The Layers: Exploring XOMA Through Analyst Insights - Markets Insider

Peeling Back The Layers: Exploring XOMA Through Analyst Insights - XOMA (NASDAQ:XOMA) - Benzinga

XOMA (NASDAQ:XOMA) Stock Passes Above Two Hundred Day Moving Average of $21.69 - Defense World

XOMA (NASDAQ:XOMA) Stock Passes Above Two Hundred Day Moving Average of $21.69 - MarketBeat

XOMA (NASDAQ:XOMA) Shares Cross Above Two Hundred Day Moving Average of $21.69 - MarketBeat

Xoma (XOMA) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Lifestyle UK

Where are the Opportunities in (XOMAP) - Stock Traders Daily

(XOMAO) Technical Data - Stock Traders Daily

When the Price of (XOMA) Talks, People Listen - Stock Traders Daily

XOMA (NASDAQ:XOMA) Shares Cross Above 200 Day Moving Average of $21.30 - MarketBeat

Objective long/short (XOMAP) Report - Stock Traders Daily

Trend Tracker for (XOMAO) - Stock Traders Daily

(XOMA) Investment Analysis - Stock Traders Daily

XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ - GlobeNewswire

XOMAOに似た銘柄